APA (7th ed.) Citation

Jr, S. H., JS, S., R, T., HR, K., SJ, M., N, S., . . . AR, R. (2012). Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism, 64(3), 876. https://doi.org/10.1002/art.33412

Chicago Style (17th ed.) Citation

Jr, Schumacher HR, et al. "Rilonacept (interleukin-1 Trap) in the Prevention of Acute Gout Flares During Initiation of Urate-lowering Therapy: Results of a Phase II Randomized, Double-blind, Placebo-controlled Trial." Arthritis and Rheumatism 64, no. 3 (2012): 876. https://doi.org/10.1002/art.33412.

MLA (9th ed.) Citation

Jr, Schumacher HR, et al. "Rilonacept (interleukin-1 Trap) in the Prevention of Acute Gout Flares During Initiation of Urate-lowering Therapy: Results of a Phase II Randomized, Double-blind, Placebo-controlled Trial." Arthritis and Rheumatism, vol. 64, no. 3, 2012, p. 876, https://doi.org/10.1002/art.33412.